Publication | Closed Access

An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration

Ocular DiseaseVitreous BodyOptical Coherence Tomography-guidedOphthalmologyAge-related DiseasesGlaucomaMedicineIntravitreal RanibizumabRadiology